Veragene + SMA
https://medgen.si/storitve/nipt-test-veragene/
NIPT going one step further
VERAgene + SMA is the only non-invasive prenatal test that simultaneously analyses aneuploidy, microdeletions
and monogenic diseases. The diseases screened by VERAgene are associated with a moderate to severe
phenotype with a significant impact on quality of life.
VERAgene + SMA provides a risk assessment for the most common chromosomal abnormalities and also predicts
the likelihood that a fetus has received both copies of a genetic mutation from its biological parents that may
cause it to develop a rare but severe genetic disease. It analyses 101 monogenic diseases, including
cystic fibrosis, spinal muscular atrophy, etc.
The cumulative risk of a fetus being affected by one of the genetic conditions screened for
by VERAgene+SMA is approximately 1 in 50 based on high- and moderate-risk pregnancies.
Analyses 101 monogenic diseases
VERAgene analyses 101 monogenic diseases including cystic fibrosis and spinal muscular
atrophy. Single gene diseases - unlike aneuploidies - have no risk associated with the age
of the mother and most of them have no chemical or ultrasound biomarkers that could help
early detection. The cumulative risk of a foetus being affected by one of the genetic conditions
screened for by VERAgene is 1 in 50 in moderate to high risk pregnant women and may be higher in
some ethnic populations where certain conditions are more prevalent. VERAgene can accurately
screen for these conditions and help parents make informed decisions about possible treatments and
clinical management.
Extremely high reliability of results
By targeting chromosome analysis, VERAgene®+ SMA achieves greater depth, which means that the results are even
more reliable, which is crucial when making decisions about the health of the unborn baby.
Who is it for?
- Pregnant women of all ages who have been pregnant for at least 10 weeks
- Singleton and biparturient pregnancies
- Couples who have not been tested for the carriage of inherited diseases before becoming pregnant
- To pregnancies with a missing twin
- Pregnancies after IVF with own cells (singleton, twin, vanishing twin)